Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
MD Anderson
Mar 13, 2024, 09:16 |
Blog
Vivek Subbiah: Privileged to collaborate with SCRI pillars Lisa Morrissey and Suzanne Jones
Vivek Subbiah shared a post on LinkedIn: "Privileged to collaborate with SCRI pillars Lisa Morrissey and…
Mar 12, 2024, 23:25 |
Blog
Vivek Subbiah: So honored to Chair the AACR PLENARY session on April 10th, 2024 at AACR24 San Diego
Vivek Subbiah shared a post on X: “ANNOUNCEMENT! MARK your calendars! So honored to Chair the…
Mar 12, 2024, 15:53 |
Blog
Naveen Pemmaraju: Congratulations to Kuo-Kai Chin for being awarded the Ruben Mesa Junior Clinical Investigator Award
Naveen Pemmaraju posted on X/Twitter: ''Congratulations to Kuo-Kai Chin for being awarded the Ruben Mesa…
Mar 12, 2024, 15:20 |
Blog
Ishwaria Subbiah: Honored to be a part of the inaugural Women Thought Leaders in Oncology hosted by TOPS
Ishwaria Subbiah shared a post on LinkedIn: "What a day! Honored to be a part…
Mar 12, 2024, 14:59 |
Blog
Tulsi Jose: Considering a leadership role before hemeonc fellowship?
Tulsi Jose, Founder of ASCO Resident Interest Group, shared on X/Twitter: “Med Twitter Considering a leadership…
Mar 12, 2024, 10:02 |
Blog
Vivek Subbiah: Grateful to have Jason Dorsey deliver a phenomenal and energetic keynote at the 27th Annual Scientific Meeting of SCRI!
Vivek Subbiah shared a post on LinkedIn: "Grateful to have Jason Dorsey an acclaimed speaker, deliver…
Mar 11, 2024, 21:06 |
Blog
Vivek Subbiah: It’s the best time to work in oncology drug development
Vivek Subbiah recently shared on LinkedIn: “It’s the best time to work in oncology drug development!…
Mar 10, 2024, 21:03 |
Blog
Vivek Subbiah: Research should be standard-of-care and standard-of-care should be research
Vivek Subbiah recently posted on LinkedIn: "Yes! “Research should be standard-of-care and standard-of-care should be research”!!!…
Mar 10, 2024, 20:49 |
Insight
Hagop Kantarjian: In this phase 2 study, a convenient, fully-oral regimen was effective and safe in an older/unfit population with acute myeloid leukemia
Hagop Kantarjian, a Professor and Chair of the Department of Leukemia at The University…
Mar 10, 2024, 12:31 |
Drugs
Fadi Haddad: P1/2 study of pivekimab
Fadi Haddad, Assistant Professor, Leukemia Department MD Anderson Cancer Center, Houston, shared a post on X/Twitter:…
124
125
126
127
128
All:
1560
Posts:
1251 - 1260
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Targeted Therapy vs Immunotherapy: Which Is Right for You, Key Differences & Similarities
ASTRO 24: 15 Posts Not to Miss From Day 2
Julia Louis-Dreyfus and Breast Cancer: How She Went Against, How She Survived, and More
ASTRO24: 20 Posts Not To Miss From Day 1
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube